search
Back to results

Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1

Primary Purpose

Substance-Related Disorders

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Behavior Therapy
Sponsored by
Yale University
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Substance-Related Disorders focused on measuring substance use disorder

Eligibility Criteria

18 Years - 99 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Individuals will be eligible for the protocol who: Are seeking outpatient treatment for any substance use disorder Are willing to participate in the protocol (e.g., to be randomized to treatment, be contacted for follow-up assessment, to have their sessions audiotaped) Are able to understand and provide written informed consent Exclusion Criteria: Individuals will be excluded who: Are not sufficiently medically or psychiatrically stable to participate in outpatient treatment Are seeking detoxification only, methadone maintenance treatment or residential inpatient treatment

Sites / Locations

  • Haight Ashbury Free Clinics
  • Tarzana Treatment Center
  • CT Renaissance, Inc.
  • LMG Programs, Inc.
  • Rehab After Work
  • Northeast Treatment Center

Outcomes

Primary Outcome Measures

Drug use
Retention
HIV risk behaviors
Psychosocial functioning

Secondary Outcome Measures

Full Information

First Posted
April 5, 2002
Last Updated
January 11, 2017
Sponsor
Yale University
search

1. Study Identification

Unique Protocol Identification Number
NCT00032981
Brief Title
Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
Official Title
Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
Study Type
Interventional

2. Study Status

Record Verification Date
April 2010
Overall Recruitment Status
Completed
Study Start Date
May 2001 (undefined)
Primary Completion Date
August 2004 (Actual)
Study Completion Date
August 2004 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Yale University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to evaluate the therapeutic usefulness of incorporating Motivational Enhancement Treatment into the standard drug abuse treatment entry process of Community Treatment Programs on improving treatment engagement, retention, and outcome.
Detailed Description
Participants seeking treatment at the participating CTPs will be randomly assigned to either "standard" or "MET/MI" treatment, with a 1- and 3-month follow-up. Primary outcome measures will include (1) treatment retention (e.g., number of sessions/weeks completed, the rate of patients completing 3 or more subsequent sessions, and (2) substance use (e.g., urinalyses, days of opioid, cocaine, marijuana, alcohol use, rates of abstinence). Secondary outcomes will include motivation, psychosocial functioning, HIV risk behaviors, treatment utilization, and patient satisfaction. Process assessments will include measures of the working alliance as well as therapist adherence/competence ratings which will evaluate how effectively MET/MI was implemented. Participating CTPs will implement one of two independent protocols, depending on which is the best suited or feasible for the intake procedures at their clinic. Thus, following an invitation to participate, explanation of the study, and provision of informed consent, patients would complete a brief assessment battery followed by either: 1) Random assignment to 3 individual sessions of standard treatment (treatment as usual) at the program versus 3 individual sessions of MET. or 2) Random assignment to 1 individual standard assessment/evaluation session.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Substance-Related Disorders
Keywords
substance use disorder

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Allocation
Randomized
Enrollment
561 (false)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
Behavior Therapy
Primary Outcome Measure Information:
Title
Drug use
Title
Retention
Title
HIV risk behaviors
Title
Psychosocial functioning

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Individuals will be eligible for the protocol who: Are seeking outpatient treatment for any substance use disorder Are willing to participate in the protocol (e.g., to be randomized to treatment, be contacted for follow-up assessment, to have their sessions audiotaped) Are able to understand and provide written informed consent Exclusion Criteria: Individuals will be excluded who: Are not sufficiently medically or psychiatrically stable to participate in outpatient treatment Are seeking detoxification only, methadone maintenance treatment or residential inpatient treatment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kathleen Carroll, Ph.D.
Organizational Affiliation
VA Connecticut Healthcare System
Official's Role
Principal Investigator
Facility Information:
Facility Name
Haight Ashbury Free Clinics
City
San Francisco
State/Province
California
ZIP/Postal Code
94117
Country
United States
Facility Name
Tarzana Treatment Center
City
Tarzana
State/Province
California
ZIP/Postal Code
91356
Country
United States
Facility Name
CT Renaissance, Inc.
City
Norwalk
State/Province
Connecticut
ZIP/Postal Code
06852
Country
United States
Facility Name
LMG Programs, Inc.
City
Stamford
State/Province
Connecticut
ZIP/Postal Code
06901
Country
United States
Facility Name
Rehab After Work
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19103
Country
United States
Facility Name
Northeast Treatment Center
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19123
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1

We'll reach out to this number within 24 hrs